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Abstract
Background: Aboriginal women experience disproportionately higher rates of cervical cancer mortality yet are less
likely to participate in screening for early detection. This study sought to determine whether a community-based
HPV self-sampling service model can effectively recruit never-screened and under-screened Aboriginal women to
participate in cervical cancer screening; assess the clinical outcomes; and explore the acceptability of the model
from the perspective of the participants.
Methods: Aboriginal women aged 25–69 years of age were recruited from eight rural and remote communities in
New South Wales, Australia to participate in HPV self-sampling via a community-based service model. Outcome
measures were: number of women screened by HPV self-sampling, their prior cervical screening status (under-
screened or never-screened), clinical outcomes and participation in follow-up pathways of care, and satisfaction
with the service model.
Results: In total, 215 women conducted a HPV self-sampling test and 200 evaluation surveys were completed. One-
fifth of participants (n = 46) were never-screened and one-third (n = 69) were under-screened. Many were unsure of
their screening status. Nine women were HPV 16/18 positive and eight had completed all follow up by the
conclusion of the study. A further 30 women tested positive for a high risk type other than HPV 16/18 (HPV other),
of which 14 had completed follow up at the conclusion of the study. Satisfaction with the HPV self-sampling kit,
the process of self-sampling and the service model was high (> 92% satisfied on all items). Many women had
difficulty understanding their official HPV results and placed high importance on the nurse explaining it to them.
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Conclusions: A community-based service model that respects Aboriginal Women’s Business can effectively recruit
under-screened and never-screened Aboriginal women to complete cervical cancer screening. Furthermore, this
service model supports them to complete recommended follow-up care and engage with their local existing
health services.
Keywords: Aboriginal women, Cervical screening, Program evaluation, Aboriginal Women’s business, Cancer
Background
In December 2017, the Australian National Cervical
Screening Program (NCSP) was updated, with HPV test-
ing replacing Pap tests. Other changes include an in-
crease in entry age from 18 to 25 years, and
recommended screening every five years (previously two
years). Also, clinician-supervised, HPV self-sampling be-
came available to eligible women. To be eligible for self-
sampling, a woman must be aged 30 years or over and
be overdue for screening by at least two years [1]. This
change was based on extensive evidence demonstrating
that HPV testing is a more sensitive screening test, pro-
viding better protection against cervical cancer through
detection of HPV before cell changes occur in the cervix
[2–4]. Key to the NCSP’s success however, is in effect-
ively recruiting women to participate in screening.
Never-screened or under-screened women are at higher
risk of cervical cancer than those who regularly partici-
pate in screening programs [5–7].This recent change to
HPV testing and the ability to self-sample provides a
unique opportunity to engage these women.
National cervical screening rates for Aboriginal and
Torres Strait Islander women is unknown as pathology
forms do not record Indigenous status. However, several
studies that have utilised community level and State/
Territory data have indicated that the average screening
rates for Indigenous women lies between 33.5 and 44%,
compared to 55.7–59.1% for non-Indigenous women…
[8–12] Aboriginal and Torres Strait Islander women also
experience higher rates of cervical cancer incidence and
mortality [12, 13], hence, increasing their participation
in preventative screening is crucial.
International research aimed at increasing the uptake
of cervical screening was summarised in a recent meta-
analysis [14]. The study found that door-to-door recruit-
ment was most effective at increasing screening uptake
as compared to clinician-collected samples. This was
followed by community campaigns and mail-out to all,
with the opt-in approach considered ineffective. How-
ever, the success of these recruitment techniques varied
across populations and geographical regions, and thus
techniques need to be tailored to specific regions. The
best way to offer self-sampling to women who are disen-
gaged from the health system and are under- or never-
screened is also not yet known. To our knowledge, no
other programs in Australia have offered face-to-face
distribution and collection of HPV self-sampling kits
within the home and community. One Australian study
successfully recruited Aboriginal women from a regional
Aboriginal Community Controlled Health Service to
participate in self-sampling [15], suggesting self-
sampling is an acceptable option for Aboriginal and
Torres Strait Islander women. No HPV self-collection
studies have specifically targeted Aboriginal and Torres
Strait Islander women in rural and remote communities.
The option of clinician-supervised patient self-
sampling under the new NCSP could positively impact
screening practices of women who have never been
screened or are under-screened. However, this pathway
relies on existing patient engagement with a clinician
and/or health service. If a woman does not routinely en-
gage with a primary healthcare service, opportunities to
actively encourage screening via this pathway are lim-
ited. This is particularly important in rural and remote
communities where access to female health professionals
can be limited and the proportion of under-screened
and never-screened women increases. Innovative models
of care are needed to engage these hard-to-reach
women. This research sought to: determine whether a
community based HPV self-sampling model effectively
recruited never-screened and under-screened Aboriginal
women to participate in cervical cancer screening; assess
the clinical outcomes, including follow-up; and explore




Marathon Health Primary Health Care Nurses (PHCNs)
consulted extensively with local organisations and com-
munity members across rural and remote New South
Wales, Australia to establish the new service model for
HPV self-sampling amongst Aboriginal women, includ-
ing clinical governance processes.
Pilot sites
Eight rural and remote communities participated in the
pilot study. Notably, seven of these had minimal access
to female General Practitioners (GPs). Our target sample
size (n = 266) was calculated based on the estimated
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number of Aboriginal women who were under-screened.
Across the study region in 2011, the total female Abori-
ginal population was 596 and an estimated 45% of
women (both Aboriginal and non-Aboriginal) were
under-screened (data provided by the NSW Cancer In-
stitute, 2011–13). Self-sampling pathway: PHCNs estab-
lished partnerships with Local Aboriginal Land Councils
(LALC) as the representative body for Aboriginal people
in each community. Each LALC identified a female em-
ployee or community member to recruit as the Commu-
nity Engagement Worker (CEW) for each site. Their
primary role was to engage and recruit women to the
program, and support them along the self-sampling
pathway, with clinical support provided by the PHCN.
Once the women completed the self-sample with the
support of the PHCN and CEW, the PHCN sent the
HPV samples to the VCS Foundation to be analysed.
Pathology results were returned by mail to the partici-
pant, their nominated GP and the PHCN. A project GP
was recruited to provide clinical oversight of those par-
ticipants who did not have a regular GP. The PHCN
followed up with all participants face-to-face or by
phone to ensure they received their results and that they
understood their meaning, including any follow-up that
was required. Women who returned invalid results were
provided the option to rescreen. See Fig. 1 for a detailed
flowchart of the self-sampling process.
Recruitment of women
The CEWs were members of the local Aboriginal com-
munity themselves, and had existing links with the com-
munity to identify and engage with local women about
the program. Whilst some women were recruited at
local community events, the majority were recruited via
home visits. Convenience sampling was used to recruit
women, followed by snowballing (referred to as the
“Koori Grapevine” by the local Aboriginal women) with
the women identifying other family and friends for cer-
vical screening. Whilst this inevitably would have re-
sulted in bias, gaining trust with the community and
having the women take on some ownership increased
acceptance of the program. .
Participants
The renewed NCSP recommends clinician-led HPV
screening for women in the age range 25–69 years (in-
clusive), therefore our study included women in this age
range. It is worth noting however, that the current NCSP
only permits self-sampling to be completed at 30 years
of age, when a woman is at least 5 years overdue for
screening. Screening of women younger than 25 years
was allowed at the discretion of the PHCN based on
clinical indication (for example, sexual debut younger
than 14 years of age and have not received the HPV
vaccination). The NCSP recommends all women con-
duct an ‘exit-screen’ between 70 and 74 years of age. We
elected not to include women in this age group so as to
ensure they conducted their recommended exit screen
outside of this pilot study under the guidance of their
clinician.
Whilst we sought to recruit women who were under-
screened, the CEW and PHCN were able to decide
whether they believed it was clinically and ethically ap-
propriate to screen women who had been screened in
the previous 4 years, particularly if they were due for a
screen or were overdue.
Data collection and management
An eligibility survey was conducted at the outset of the
recruitment process. An evaluation survey was con-
ducted during follow-up to elicit feedback on the service
model and the participant’s experience of self-sampling
using likert scale responses from 1 (very unsatisfied) to 5
(very satisfied). Clinical data were input into the client’s
electronic medical record as per routine practice. All
data were stored securely and confidentially so as to
comply with both clinical governance requirements and
research ethics requirements.
All data were linked using a code number and then
de-identified by the PHCN before analysis by the re-
search team. Data were entered into Excel. IBM SPSS
Statistics (version 22) was used for descriptive statistics
on the quantitative dataset. Open-ended comments were
combined and key themes then extracted by two re-
searchers independently as part of the manifest content
analysis process [16]. Themes and sub-themes were
compared and discussed until a consensus was reached.
Ethics approval
Ethics approval was granted by the Aboriginal Health
and Medical Research Council Human Research Ethics
Committee (reference 1188/16) and Western Sydney
University Human Research Ethics Committee (reference
H11837).
Results
Part 1: clinical results
HPV self-sampling kits were distributed from September
2016 to June 2018 (21 months). The 215 women (80.8%
of the targeted sample) that agreed to participate were
all eligible and completed the HPV self-sample. Partici-
pation was highest amongst women aged 25–29 years
(Fig. 2).
One-fifth of participants (21.4%, 46) self-reported that
they had never completed a Pap test and 32.1% (69) had
previously completed a Pap test but more than 4 years
ago, with the range since last Pap test being 4 to 20
years. A total of 26.0% (56) of participating women
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Fig. 1 Study flowchart
Fig. 2 Age distribution of women that participated in HPV self-sampling
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reported that they had been screened, but could not re-
member when, suggesting that it was more than 4 years
ago. Of the 34 (15.8%) women that had been screened in
the previous 4 years, all but thirteen (6%) had not been
screened in the previous two years, and thus were due
for screening. Last screen was not recorded or was
unknown for 10 (4.7%) participants.
Eighteen percent (18.1%; 39) of women had a positive
result: 4.2% [9] were HPV Positive 16/18 and 14% (30)
HPV Positive other (defined as a high risk HPV type
other than 16 or 18). Seventy-eight percent (78%, 168)
had a negative result (two of which were the results of a
second screen as the initial result was invalid), and 3.7%
[8] had invalid results and did not complete a rescreen.
Stratification by age group showed that women who
tested positive were distributed across all of the age
groups (Table 1).
Eight of the nine women (88.9%) with a HPV Positive
16/18 result had attended a colposcopy appointment by
mid-July 2018. The other woman failed to attend her ap-
pointments due to documented clinical and other issues.
Just under half (46.7%; 14) of the women with a HPV
Positive other result had attended an appointment for a
cervical screen by mid-July 2018 when this study ended.
Attendance at follow-up appointments was relatively
similar regardless of cervical screening history (Fig. 3).
Part 2: Women’s satisfaction and feedback
Almost all women (92.6%; 199) completed the follow-up
evaluation survey. One completed the survey twice as
her initial result was invalid (200 total surveys). More
than 90% of women were highly satisfied with the HPV
self-sampling kit and the process involved (Table 2). In
response to whether results were presented in an easy to
understand format, 13.2% (23) were unsatisfied or very
unsatisfied. Further, some women that were highly satis-
fied with the format of results commented that they
were unable to interpret the paper copy independently,
but the PHCN explained the results well:
“The pathology made no sense to me but when the
Nurse called and discussed I understood them”.
Fig. 3 Follow-up rate of women who tested positive for HPV by cervical screening status
Table 1 HPV test results stratified by age group
HPV Test Result Negative Positive for HPV 16/18 type Positive for a type other than HPV 16/18
Age Group
< 25 years 8 (4.8%) 0 5 (12.8%)
25–29 years 27 (16.1%) 1 (11.1%) 10 (25.6%)
30–34 years 27 (16.1%) 1 (11.1%) 4 (10.3%)
35–39 years 22 (13.1%) 2 (22.2%) 6 (15.4%)
40–44 years 20 (11.9%) 0 5 (12.8%)
45–49 years 19 (11.3%) 2 (22.2%) 3 (7.7%)
50–54 years 18 (10.7%) 1 (11.1%) 2 (5.1%)
55–59 years 11 (6.5%) 0 2 (5.1%)
60–64 years 12 (7.1%) 2 (22.2%) 2 (5.1%)
65 years and over 4 (2.4%) 0 0
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The majority of participants (96.0%; 192) would use
the HPV self-sampling kit again. Of the six women who
stated they would not use it again, four were referred to
the GP for a pap test and would thus go directly to the
GP next time, and two experienced difficulties complet-
ing the sample. Almost all women (98.5%; 197) would
recommend the HPV self-sampling kit to other women.
Women were grateful of, and highly satisfied with, the
service (Table 3). There was overwhelming agreement
that self-sampling removed the shame, intimidation, em-
barrassment, and pain that has historically been associ-
ated with clinician-collected Pap tests. Positive aspects
included the ability to complete the test in the home,
and thus the accessibility and privacy of cervical screen-
ing; the simplicity of the test; being in charge of
Women’s business (an important consideration in Abo-
riginal culture where certain aspects of life are per-
formed separately and termed Men’s and Women’s
business [17] – cervical screening falls into this cat-
egory); the appropriateness of the self-sampling kit con-
tents, with the exception of there not being a non-
transparent bag to return the swab in; and the profes-
sionalism of the PHCN. Women felt they would not
have completed cervical screening had this service not
been available.
“I could do it myself. No pain. I ended up having to
go to the GP for a Pap test but I would have never
done that if I didn’t have a self-sample, may have
saved my life. I recommend this to everyone. The
government needs to give all women the choice to
self-sample”.
Discussion
This program successfully recruited never- and under-
screened Aboriginal women across rural and remote
Australia to participate in HPV self-sampling in the
home or community. Indeed, we were able to recruit
81% of our target sample size to participate in screening,
a value much larger than the estimated 30–40% of Abo-
riginal women who have traditionally been recruited to
participate in cervical screening [8–12]. Certainly, one-
fifth of participating women had never been screened
previously, one-third were overdue for screening, and a
further quarter could not remember when they were last
screened, suggesting it was a long time ago and they
were therefore likely to be overdue for screening.
Despite historically being disengaged from the health
system, eight of the nine women with a HPV Positive
16/18 had attended a colposcopy appointment by the
completion of the project. This is in line with other
studies that also reported high follow-up rates for
women who participated in self-sampling [13, 15]. The
lower follow-up rates (46.7%) observed for women who
tested HPV Positive Other (defined as a high risk HPV
type other than HPV 16 or 18) may be the result of not
tracking women for long enough as anecdotal evidence
provided after the completion of this study reported that
Table 2 Participating women’s level of satisfaction with the HPV self-sampling program









1.1 HPV self-sampling kit
The kit provided everything to complete the self-
sampling test? (n = 200)
199 (99.5%) 1 (0.5%) – – –
Satisfaction with the self-sampling instructions (n = 200) 196 (98.0%) 1 (0.5%) 1 (0.5%) – 2 (1%)
1.2 HPV self-sampling process
Process clearly explained by the CEW (n = 197) 188 (95.4%) 5 (2.5%) 3 (1.5%) 1 (0.5%) –
Able to ask questions and receive answers in a timely
manner? (n = 186a)
183 (98.4%) 2 (1.1%) – 1 (0.5%) –
The process was simple (n = 197) 187 (94.9%) 4 (2%) 4 (2%) – 2 (1.0%)
Provided with privacy and confidentiality (n = 197) 182 (92.4%) 6 (3.0%) 7 (3.6%) 2 (1.0%) –
1.3 Results
Results were provided in an easy to understand format
(n = 174b)
136 (78.2%) 6 (3.4%) 9 (5.2%) 3 (1.7%) 20 (11.5%)
< 2 weeks < 3
weeks
> 3 weeks Unsure Not at time PHCN made
contactc
Mailed results returned within 2 weeks (n = 195) 148 (75.9%) 13
(6.7%)
6 (3.1%) 13 (6.7%) 15 (7.7%)
a Eight participants said they did not need to ask questions and six did not respond to this question
b Some participants had not yet received results and thus not applicable or did not respond to this question
c The hard copy paper results were not yet received by the participant at the time the PHCN provided the results verbally over the phone (this may have been
within two weeks of the self-sampling test)
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some women did attend a follow up GP appointment
that occurred after the end date of this study. Long-term
research is therefore needed to understand whether
follow-up care is achieved and how women can best be
supported.
Given the target population was not actively engaged
in cervical cancer screening or the health system, the
timely and individual support the PHCN and CEW pro-
vided to each woman to ensure results and follow-up
care were understood, and women remained engaged,
was key to the model’s success. Women placed high im-
portance on the verbal communication of results given
by the PHCN, particularly as they did not understand
the hard copy results. Ensuring women have maximum
Table 3 Participating women’s experiences with HPV self-sampling
Themes Description
Location of self-sample In the home: Women felt it was a more private, confidential and comfortable
experience; they could complete it without embarrassment and shame.
Out of the home: There was mixed feelings regarding privacy and confidentiality
when completed out of the home (e.g. park, LALC, mother’s groups).
Accessible Accessible (in the home) and free. No need to travel long distances for a female GP,
or wait and pay at a General Practice.
Privacy and confidentiality – shame and embarrassment Self-sampling was private and confidential, with no shame or embarrassment.
Women did not feel violated or lose their dignity.
Simplicity Self-sampling was described as simple, easy, convenient, quick, and not too
daunting.
Several women experienced some difficulty completing the test themselves.
In charge of Aboriginal women’s businessa Women felt a sense of control over their own women’s business, health and
wellbeing. Women found it to be a positive and personal experience, and they felt
comfortable and at ease.
Comparison of HPV self-sampling to Pap test Pap test – uncomfortable, painful, humiliating, daunting, shameful, embarrassing,
degrading, intimidating, not confidential. Women do not like going to the Doctor
and do not want a man involved in women’s business.
HPV self-sampling – easier, more private, discreet, comfortable, personal, dignified,
appropriate, and quicker. Not as intrusive, evasive or awkward.
Self-sampling kit contents High importance was place on the quality of the instruction cards:
(a) They were clear, easy to understand, straight forward – not having to sift through
unnecessary readings.
(b) Illustrations for black women were good.
In the case a woman could not read, the Nurse could clearly explain the process
and the picture cards supported this.
The women were happy they could keep the case the kit came in.
A non-transparent bag needs to be included in the kit for the sample to be returned
to improve privacy and remove any shame.
The PHCN gave the women confidence in the service being
professional
Women placed high importance on a trained professional (i.e. the PHCN) being
present throughout the program, giving them confidence that it was accurate and
professional. Some women would have preferred the PHCN (instead of the CEW) to
explain the kit/process and take the completed sample.
Verbal communication of results Women appreciated the verbal communication of results from the PHCN,
particularly as many women could not understand them. This was described as
‘caring’ and gave women confidence in the entire program.
Unlikely that women would have completed a cervical screen
had the HPV self-sampling test not been offered
Women commented on: never having completed a cervical screen until
participating in this study; being hesitant, reluctant, frightened, or scared to go to
the Doctor to have a cervical screen, even in the case that one woman had a family
history of cervical cancer and understood the risks; postponing Pap tests, with
women suggesting anywhere between 1 and 20 years before they thought they
would be screened again.
Grateful of a potential lifesaving experience Women (irrelevant of results) were grateful and happy they had been offered the
self-sampling kit, and that it could have saved their lives.
Initial concerns with the Program Women were not always forthcoming to completing the self-sampling, describing
that they were initially nervous (e.g. unsure of accuracy of the test; previous painful
experience with a pap test; worried of a positive result). However, these comments
were followed by positive feedback about the test and increased confidence to
complete the test next time.
a In Aboriginal culture, certain aspects of life are performed separately for men and women, and are termed Men’s business and Women’s business [17]; cervical
screening and related items fall into this category
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understanding of the next steps in their pathway of care
decreases anxiety and assists with successful completion
of the self-sampling pathway [18]. Flexibility in PHCN
and CEW roles enabled innovative solutions to be
adapted for each woman to support them at an individ-
ual level to access the follow-up care required. This in-
cluded offering self-sampling in the home environment.
The majority of self-sampling studies have not allowed
for home-based self-collection so this study adds to the
limited evidence base attesting to its effectiveness at en-
gaging women to complete screening.
There was overwhelming agreement that this method
for cervical cancer screening is appropriate for Aborigi-
nal women, ensuring Aboriginal Women’s Business is
respected. In comparison to Pap tests it was seen as a
positive experience which women were happy to repeat
and recommend to others, also documented in numer-
ous self-sampling trials [18–21]. Importantly, women
mentioned they would not have participated in screening
had this not been available.
This pilot highlighted how the model can provide an
access point into the health system, demonstrated by the
large proportion of women that entered the mainstream
health system for follow-up care. Further, an unexpected
outcome was that some women who attended a GP
follow-up appointment, also sought after additional
medical advice/treatment for other conditions. It pro-
vided a comfortable access point for these women, and
therefore can have a net overall positive impact on
health service engagement.
Whilst the current NCSP supports never- and under-
screened women to participate in self-sampling rather
than clinician-led sampling, there are specific criteria
and it must be facilitated and requested by a clinician
who routinely performs cervical screening. Hence, it is
reliant on existing engagement with a clinician/health
service. The current community-based service model
could serve as an effective adjunct to clinician-led NCSP
services by engaging with those women who are cur-
rently not engaged with a health service or clinician. Sig-
nificantly, data from this study shows that this service
model can also facilitate health service engagement
amongst women who were previously disengaged. For
many women though, the barriers to engagement with
cervical screening under the previous NCSP will not im-
mediately be broken down by completing one self-
sample HPV test. It is a key recommendation of this
study that women who are eligible for self-sampling con-
tinue to remain eligible to screen via this pathway,
should they decline clinician-led screening in the future.
Limitations
This study did not capture numbers of women who were
approached and declined participation or were obviously
ineligible, such as being pregnant. Screening history was
self-reported and thus there may have been some error
in this data. There was not a structured process in place
to document the follow-up outcomes for women and
support required, including a formal clinical record re-
view to determine actual disease burden from biopsy re-
sults. When women completed the evaluation survey
there was a feeling that using a scale of 1 to 5 was not
always understood by the women, and that a yes/no re-
sponse (or something similar) would be more appropri-
ate. The data collection timeframe was longer than
anticipated (21 months) and this was due to a number of
external factors along with workforce challenges in
retaining CEWs in some of the communities. For rea-
sons unrelated to the project, a number of CEWs relo-
cated to other regions and new CEWS had to be
recruited. Nonetheless, these are important consider-
ations when scaling up services such as this across the
region, particularly in rural and remote areas where
health workforce is already a challenge.
Conclusions
This pilot demonstrated how a community-based model
that respects Aboriginal Women’s Business, is
community-led, and has a clinical lead to maintain high
clinical governance and professionalism within the pro-
gram, can effectively recruit hard-to-reach under-
screened and never-screened Aboriginal women to
complete cervical cancer screening. This was evidenced
through high screening participation rates, high levels of
satisfaction amongst participating women and the high
rates of women engaging with recommended follow-up
care. It is extremely unlikely that these women would
have engaged in the current NCSP via clinician-
supervised self-sampling as they are not engaged in the
health system (i.e. they do not visit GPs). Future research
and evaluation is needed to explore translation of this
best practice service model into other remote, rural and
regional sites. Research that builds on the current pilot
study data can inform the requirements of rolling out
this service model to communities that differ by popula-
tion size, remoteness, geography, health service access,
and other aspects unique to that community. Long-term
follow-up of HPV self-sampling participants can also
shed light on the ongoing health service engagement
and cervical screening practices of these women.
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